Thirteen genes were identified as influential in subtyping patients in both the primary and validation datasets, with three—TOP2A, DCN, and MT1E—showing significant associations with survival and recurrence in HCC (Fig. 8). The gene discussed is DCN; the disease is hepatocellular carcinoma.